By Josh Beckerman

 

Certara Inc. shares fell 15% to $17.24 after the biosimulation company said certain stockholders including EQT AB plan to sell 7 million shares.

On Tuesday, Certara said second-quarter revenue rose 18% to $82.8 million, but added that it expects foreign exchange impact and softness in regulatory services to continue in the second half of the year.

 

Write to Josh Beckerman at josh.beckerman@wsj.com

 

(END) Dow Jones Newswires

August 12, 2022 13:20 ET (17:20 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Certara (NASDAQ:CERT)
Historical Stock Chart
From Aug 2022 to Sep 2022 Click Here for more Certara Charts.
Certara (NASDAQ:CERT)
Historical Stock Chart
From Sep 2021 to Sep 2022 Click Here for more Certara Charts.